LGE Means Better Selection of HCM Patients for Primary Prevention Implantable Defibrillators ∗
- 1 December 2016
- journal article
- Published by Elsevier BV in JACC: Cardiovascular Imaging
- Vol. 9 (12), 1403-1406
- https://doi.org/10.1016/j.jcmg.2016.01.032
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Clinical Impact of Contemporary Cardiovascular Magnetic Resonance Imaging in Hypertrophic CardiomyopathyCirculation, 2015
- Hypertrophic Cardiomyopathy in Adulthood Associated With Low Cardiovascular Mortality With Contemporary Management StrategiesJournal of the American College of Cardiology, 2015
- 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathyEuropean Heart Journal, 2014
- Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic CardiomyopathyCirculation, 2014
- Hypertrophic CardiomyopathyJournal of the American College of Cardiology, 2014
- Risk of Sudden Death and Outcome in Patients With Hypertrophic Cardiomyopathy With Benign Presentation and Without Risk FactorsThe American Journal of Cardiology, 2014
- Prevention of Sudden Cardiac Death With Implantable Cardioverter-Defibrillators in Children and Adolescents With Hypertrophic CardiomyopathyJournal of the American College of Cardiology, 2013
- 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic SurgeonsJournal of the American College of Cardiology, 2011
- Contemporary Insights and Strategies for Risk Stratification and Prevention of Sudden Death in Hypertrophic CardiomyopathyCirculation, 2010
- Implantable Cardioverter-Defibrillators and Prevention of Sudden Cardiac Death in Hypertrophic CardiomyopathyJAMA, 2007